Inhaler
Latest AstraZeneca AB Patents:
- Arginase inhibitors and methods of use thereof
- Spirocyclic compounds
- METHODS OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME
- Arginase inhibitors and methods of use thereof
- Methods of treating heart failure with reduced ejection fraction
Description
FIG. 1 is a perspective view of an inhaler in closed condition showing our design:
FIG. 2 is a perspective view thereof, with the inhaler in open condition and suction tube in stored position;
FIG. 3 is a perspective view thereof, with the inhaler in open condition and suction tube in usable position;
FIG. 4 is an end elevation view thereof, with the inhaler in open condition and suction tube in usable position; and,
FIG. 5 is a side elevation view thereof, with the inhaler in open condition and suction tube in usable position.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D493519
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Jul 27, 2004
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Jan Jönsson (Lund), Patrik Månsson (Malmö), Malin Orebäck (Bromma)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/172,890
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Jul 27, 2004
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Jan Jönsson (Lund), Patrik Månsson (Malmö), Malin Orebäck (Bromma)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/172,890
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;